The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

AstraZeneca PLC

NYSE: AZN
Last

(U.S.) $26.27

Today's change0.00 0.00%
Updated December 8 4:03 PM EST. Delayed by at least 15 minutes.
 

AstraZeneca PLC

NYSE: AZN
Last

(U.S.) $26.27

Today's change0.00 0.00%
Updated December 8 4:03 PM EST. Delayed by at least 15 minutes.

AstraZeneca PLC closed at (U.S.)$26.27.

Over the last five days, shares have gained 1.78%, but sit 2.82% above the 52-week low. Shares have underperformed the S&P 500 by 30.55% during the last year.

Key company metrics

  • Open(U.S.) $26.13
  • Previous close(U.S.) $26.27
  • High(U.S.) $26.32
  • Low(U.S.) $26.02
  • Bid / Ask-- / --
  • YTD % change-22.62%
  • Volume7,212,763
  • Average volume (10-day)8,746,499
  • Average volume (1-month)8,245,494
  • Average volume (3-month)6,008,158
  • 52-week range(U.S.) $25.55 to (U.S.) $35.04
  • Beta0.75
  • Trailing P/E26.97×
  • P/E 1 year forward12.72×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend(U.S.) $1.40
  • Dividend yield5.33%
  • Trailing EPS(U.S.) $0.97
Updated December 8 4:03 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+10.06%

Based on its net profit margin of 10.06%, AstraZeneca PLC is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.38%Sector:Industry:
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue5,6995,6036,1156,399
Total other revenue--------
Total revenue5,6995,6036,1156,399
Gross profit4,8584,5605,1205,164
Total cost of revenue8411,0439951,235
Total operating expense4,6715,3005,0775,311
Selling / general / administrative1,9682,1912,2032,560
Research & development1,3371,3841,4291,567
Depreciation / amortization297309263360
Interest expense (income), net operating--------
Unusual expense (income)33576526382
Other operating expenses, total-107-392-76-493
Operating income1,0283031,0381,088
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax676-30723802
Income after tax995-31625808
Income tax, total-319198-6
Net income1,014-3646808
Total adjustments to net income--------
Net income before extra. items1,014-3646808
Minority interest1928210
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,014-3646808
Inc. avail. to common incl. extra. items1,014-3646808
Diluted net income1,014-3646808
Dilution adjustment0--00
Diluted weighted average shares1,2661,2651,2651,265
Diluted EPS excluding extraordinary itemsvalue per share0.800.000.510.64
Dividends per sharevalue per share0.000.900.001.90
Diluted normalized EPSvalue per share1.070.590.731.49